As of 2025-07-16, the EV/EBITDA ratio of Pieris Pharmaceuticals Inc (PIRS) is -5.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PIRS's latest enterprise value is 93.79 mil USD. PIRS's TTM EBITDA according to its financial statements is -18.00 mil USD. Dividing these 2 quantities gives us the above PIRS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 12.9x | 11.9x |
| Forward P/E multiples | 11.7x - 22.9x | 16.1x |
| Fair Price | (23.03) - (25.62) | (27.96) |
| Upside | -269.3% - -288.4% | -305.6% |
| Date | EV/EBITDA |